Cost of off-label antibiotic therapy for bone and joint infections: a 6-year prospective monocentric observational cohort study in a referral centre for management of complex osteo-articular infections

Pham, Truong-Thanh; Mabrut, Eugénie; Cochard, Philippe; Chardon, Paul; Serrier, Hassan; Valour, Florent; Huot, Laure; Tod, Michel; Leboucher, Gilles; Chidiac, Christian; Ferry, Tristan

doi:10.5194/jbji-6-337-2021

Articles | Volume 6, issue 8

https://doi.org/10.5194/jbji-6-337-2021

© Author(s) 2021. This work is distributed under
the Creative Commons Attribution 4.0 License.

https://doi.org/10.5194/jbji-6-337-2021

© Author(s) 2021. This work is distributed under
the Creative Commons Attribution 4.0 License.

Articles | Volume 6, issue 8

Original full-length article

|

07 Sep 2021

Original full-length article |

| 07 Sep 2021

Cost of off-label antibiotic therapy for bone and joint infections: a 6-year prospective monocentric observational cohort study in a referral centre for management of complex osteo-articular infections

Truong-Thanh Pham, Eugénie Mabrut, Philippe Cochard, Paul Chardon, Hassan Serrier, Florent Valour, Laure Huot, Michel Tod, Gilles Leboucher, Christian Chidiac, and Tristan Ferry

Related authors

Re-evaluating patient isolation policies for musculoskeletal infections in orthopaedic practice: a scoping review

Laura Bessems, Jolien Onsea, Baixing Chen, Marjan Wouthuyzen-Bakker, Irene K. Sigmund, Tristan Ferry, Richard Kuehl, Martin Clauss, Alex Soriano, Ricardo Sousa, Annette Schuermans, and Willem-Jan Metsemakers

J. Bone Joint Infect., 10, 489–500, https://doi.org/10.5194/jbji-10-489-2025,https://doi.org/10.5194/jbji-10-489-2025, 2025

Short summary

Debridement, antimicrobial therapy, and implant retention (DAIR) as curative surgical strategy for acute periprosthetic hip and knee infections: a summary of the position paper from the European Bone & Joint Infection Society (EBJIS)

Irene K. Sigmund, Marjan Wouthuyzen-Bakker, Tristan Ferry, Willem-Jan Metsemakers, Martin Clauss, Alex Soriano, Rihard Trebse, and Ricardo Sousa

J. Bone Joint Infect., 10, 139–142, https://doi.org/10.5194/jbji-10-139-2025,https://doi.org/10.5194/jbji-10-139-2025, 2025

Short summary

Debridement, antimicrobial therapy, and implant retention (DAIR) as curative strategy for acute periprosthetic hip and knee infections: a position paper of the European Bone & Joint Infection Society (EBJIS)

Irene K. Sigmund, Tristan Ferry, Ricardo Sousa, Alex Soriano, Willem-Jan Metsemakers, Martin Clauss, Rihard Trebse, and Marjan Wouthuyzen-Bakker

J. Bone Joint Infect., 10, 101–138, https://doi.org/10.5194/jbji-10-101-2025,https://doi.org/10.5194/jbji-10-101-2025, 2025

Short summary

Optimized decision algorithm for the microbiological diagnosis of osteoarticular infections in adults using synovial fluid samples: a prospective study in two French hospitals including 423 samples of synovial fluid

Céline Dupieux, Ghislaine Descours, Paul Verhoeven, Florence Grattard, Yvonne Benito, François Vandenesch, Céline Cazorla, Tristan Ferry, Sébastien Lustig, Bertrand Boyer, Sandrine Boisset, Anne Carricajo, Frédéric Laurent, and PIRLA investigator group

J. Bone Joint Infect., 9, 37–48, https://doi.org/10.5194/jbji-9-37-2024,https://doi.org/10.5194/jbji-9-37-2024, 2024

Short summary

Lysins – a new armamentarium for the treatment of bone and joint infections?

Parham Sendi and Tristan Ferry

J. Bone Joint Infect., 7, 187–189, https://doi.org/10.5194/jbji-7-187-2022,https://doi.org/10.5194/jbji-7-187-2022, 2022

Osteocutaneous-flap-related osteomyelitis following mandibular reconstruction: a cohort study of an emerging and complex bone infection

Clément Javaux, Clémentine Daveau, Clotilde Bettinger, Mathieu Daurade, Céline Dupieux-Chabert, Fabien Craighero, Carine Fuchsmann, Philippe Céruse, Arnaud Gleizal, Nicolas Sigaux, Tristan Ferry, Florent Valour, and the Lyon BJI study group

J. Bone Joint Infect., 7, 127–136, https://doi.org/10.5194/jbji-7-127-2022,https://doi.org/10.5194/jbji-7-127-2022, 2022

Short summary

Cited articles

Association for Accessible Medicines: 2020 Generic Drug & Biosimilars Access & Savings in the U.S. Report, available at: https://accessiblemeds.org/2020-Access-Savings-Report, last access: 14 June 2021.

Berbari, E. F., Kanj, S. S., Kowalski, T. J., Darouiche, R. O., Widmer, A. F., Schmitt, S. K., Hendershot, E. F., Holtom, P. D., Huddleston 3rd, P. M., Petermann, G. W., Osmon, D. R., and Infectious Diseases Society of, A.: 2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults, Clin. Infect. Dis., 61, e26–46, https://doi.org/10.1093/cid/civ482, 2015.

Carvalhaes, C. G., Sader, H. S., Flamm, R. K., and Mendes, R. E.: Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA and Europe (2014–17), J. Antimicrob. Chemother., 74, 1928–1933, https://doi.org/10.1093/jac/dkz120, 2019.

da Silva, R. B. and Salles, M. J.: Outcomes and Risk Factors in Prosthetic Joint Infections by multidrug-resistant Gram-negative Bacteria: A Retrospective Cohort Study, Antibiotics (Basel), 23, 340, https://doi.org/10.3390/antibiotics10030340, 2021.

Decollogny, A., Eggli, Y., Halfon, P., and Lufkin, T. M.: Determinants of generic drug substitution in Switzerland, BMC Health Serv. Res., 11, 17, https://doi.org/10.1186/1472-6963-11-17, 2011.